L96

3-{5-cyclopropyl-3-(3,5-dimethyl-1H-pyrazol-4-yl)-2-[3-(propan-2-yloxy)phenyl]-1H-indol-1-yl}propanoic acid

Created:	2015-08-12
Last modified:	2016-06-22

Find Related PDB Entry
1 entries where L96 is found as a standalone ligand

Find related ligands:

Similar Ligands (Stereospecific) Similar Ligands (including Stereoisomers) Similar Ligands (Quick Screen) Similar Ligands (Substructure Stereospecific) Similar Ligands (Substructure including Stereoisomers)

Chemical Details
Formal Charge	0
Atom Count	65
Chiral Atom Count	0
Bond Count	69
Aromatic Bond Count	21

2D diagram of L96

Toggle Hydrogen Toggle Labels

Chemical Component Summary
Name	3-{5-cyclopropyl-3-(3,5-dimethyl-1H-pyrazol-4-yl)-2-[3-(propan-2-yloxy)phenyl]-1H-indol-1-yl}propanoic acid
Systematic Name (OpenEye OEToolkits)	3-[5-cyclopropyl-3-(3,5-dimethyl-1H-pyrazol-4-yl)-2-(3-propan-2-yloxyphenyl)indol-1-yl]propanoic acid
Formula	C₂₈ H₃₁ N₃ O₃
Molecular Weight	457.564
Type	NON-POLYMER

Chemical Descriptors
Type	Program	Version	Descriptor
SMILES	ACDLabs	12.01	O=C(O)CCn1c5c(c(c1c2cccc(c2)OC(C)C)c3c(nnc3C)C)cc(C4CC4)cc5
SMILES	CACTVS	3.385	CC(C)Oc1cccc(c1)c2n(CCC(O)=O)c3ccc(cc3c2c4c(C)[nH]nc4C)C5CC5
SMILES	OpenEye OEToolkits	1.9.2	Cc1c(c(n[nH]1)C)c2c3cc(ccc3n(c2c4cccc(c4)OC(C)C)CCC(=O)O)C5CC5
Canonical SMILES	CACTVS	3.385	CC(C)Oc1cccc(c1)c2n(CCC(O)=O)c3ccc(cc3c2c4c(C)[nH]nc4C)C5CC5
Canonical SMILES	OpenEye OEToolkits	1.9.2	Cc1c(c(n[nH]1)C)c2c3cc(ccc3n(c2c4cccc(c4)OC(C)C)CCC(=O)O)C5CC5
InChI	InChI	1.03	InChI=1S/C28H31N3O3/c1-16(2)34-22-7-5-6-21(14-22)28-27(26-17(3)29-30-18(26)4)23-15-20(19-8-9-19)10-11-24(23)31(28)13-12-25(32)33/h5-7,10-11,14-16,19H,8-9,12-13H2,1-4H3,(H,29,30)(H,32,33)
InChIKey	InChI	1.03	YBEJGNSQZJLYDL-UHFFFAOYSA-N

Related Resource References

Resource Name	Reference
Pharos	CHEMBL3814634
PubChem	121225428
ChEMBL	CHEMBL3814634

RCSB PDB Core Operations are funded by the U.S. National Science Foundation (DBI-2321666), the US Department of Energy (DE-SC0019749), and the National Cancer Institute, National Institute of Allergy and Infectious Diseases, and National Institute of General Medical Sciences of the National Institutes of Health under grant R01GM157729.